Bayer ‘Arm’s Length’ Firm Vividion Comes Of Age With Its Own M&A

Acquired in August 2021 by Bayer, the San Diego-based biotech has used its autonomous operating model to make a purchase of its own, taking control of its functional genomics partner Tavros.

Jigsaw

More from Deals

More from Therapy Areas